Furthermore, the presence of scattered mitosis and tumor-infiltrating lymphocytes was obvious, thus, reflecting a potential compartment to be challenged with immunostimulants; although the tumor size was significantly reduced, no histopathological changes were observed after P-MAPA and CIS treatments (Fig. 4a-e). Here, LRRC25 is linked to in situ carcinoma.